NanoVibronix Inc.'s subsidiary, ENvue Medical, has announced the launch of its innovative ENvue Drive™ platform, an intelligent robotic system designed to enhance bedside feeding tube and vascular line navigation. This next-generation development aims to automate electromagnetic navigation for enteral and vascular access procedures, addressing the need to increase procedural volume with fewer hands at the bedside. The ENvue Drive™ system integrates with FDA-cleared electromagnetic guidance technology, offering automated alignment and positional stability while allowing clinicians to maintain full control. This strategic initiative builds on ENvue Medical's momentum, including a dual-system acquisition agreement with a major Northeastern U.S. hospital and the issuance of a new U.S. patent for its electromagnetic guidance system for pediatric applications. The company continues to expand geographically across the Southeast, Midwest, and Northeastern U.S., with growing market penetration.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。